Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) Research & Development: 2018-2024

Historic Research & Development for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $163.5 million.

  • CureVac N.V's Research & Development fell 17.92% to -$39.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $146.0 million, marking a year-over-year increase of 21.90%. This contributed to the annual value of $163.5 million for FY2024, which is 31.34% up from last year.
  • Per CureVac N.V's latest filing, its Research & Development stood at $163.5 million for FY2024, which was up 31.34% from $124.5 million recorded in FY2023.
  • In the past 5 years, CureVac N.V's Research & Development ranged from a high of $933.4 million in FY2021 and a low of $63.8 million during FY2022.
  • In the last 3 years, CureVac N.V's Research & Development had a median value of $124.5 million in 2023 and averaged $117.3 million.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 587.86% in 2021, then slumped by 93.16% in 2022.
  • Over the past 5 years, CureVac N.V's Research & Development (Yearly) stood at $135.7 million in 2020, then soared by 587.86% to $933.4 million in 2021, then plummeted by 93.16% to $63.8 million in 2022, then soared by 95.11% to $124.5 million in 2023, then spiked by 31.34% to $163.5 million in 2024.